Objective
Increased systemic inflammation is associated with stress-related psychopathology. Specifically, levels of the pro-inflammatory marker C-reactive protein (CRP) are increased in individuals with posttraumatic stress disorder (PTSD). Furthermore, single nucleotide polymorphisms (SNPs) in the CRP gene are associated with CRP levels, risk for cardiovascular disease and obesity. We examined whether polymorphisms within the CRP gene and increased CRP levels are associated with PTSD symptoms and fear physiology in a highly traumatized civilian population.
Method
Cross-sectional data were collected from subjects recruited from an inner-city public hospital that serves a primarily African American, low socioeconomic population. Participants were interviewed to determine PTSD symptom severity, and a fear-potentiated startle (FPS) paradigm was administered to assess fear-related phenotypes of PTSD.
Results
One SNP within the CRP gene, rs1130864, was significantly associated with increased PTSD symptoms (N=2692; p=0.004), including ‘being overly alert’ as the most significant individual symptom (N=2698; p =1.5×10−5). Additionally CRP genotype was also associated with the odds of PTSD diagnosis (N=2692; p=0.004). This SNP was also associated with increased CRP levels (N=137; p=0.007), and high CRP levels (>3mg/L) were positively associated with PTSD symptoms (N=187; p=0.032) and FPS to a safety signal (N=135; p<0.005).
Conclusions
Together, these data indicate that genetic variability in the CRP gene is associated with increased CRP levels and PTSD symptoms, including hyperarousal symptoms. Increased CRP levels were also associated with exacerbated fear-related psychophysiology and PTSD symptoms and diagnosis. These findings offer a potential mechanism by which an increased pro-inflammatory state may lead to heightened PTSD symptoms.